Design and Simulation of an AI ‐Powered Artificial Pancreas System With Personalized Glucose Sensing and Insulin Delivery
BACKGROUND: Achieving tight glycemic control in Type 1 diabetes is challenged by non-linear metabolic dynamics and insulin-stacking risk. Artificial intelligence models offer improved personalization, but their opacity raises safety concerns, particularly for basal insulin dosing, which is often treated as static in existing decision-support systems. METHODS: We propose a hybrid closed-loop system combining a data-driven LightGBM regressor for basal dose prediction, trained on the T1D-UOM dataset, with a physiologically grounded, rule-based safety layer at the edge. Basal insulin is predicted from cyclical time encoding and glucose rate-of-change; bolus dosing follows carbohydrate intake and correction requirements. A time-bounded insulin-on-board model, an uncertainty-adaptive post-bolus damping factor, and a predictive low-glucose-suspend rule reproducing the Tandem Basal-IQ protocol together suspend or reduce delivery when residual insulin is high or hypoglycemia is projected. The system was evaluated in silico over 60 continuous days under shadow-mode replay and closed-loop reduced-order simulation, including an ablation with bolus delivery suppressed. RESULTS: U). The hybrid controller maintained Time-in-Range at 62.8% within the reduced-order closed-loop simulation, with no violations of the insulin-on-board suspension or damping rules; suppressing bolus delivery in an ablation within this simulation dropped Time-in-Range to 26.1%, indicating that, within the reduced-order model, bolus delivery is a determinant of simulated glycemic outcome. CONCLUSIONS: The proposed architecture demonstrates a safety-audited template for combining machine-learning basal prediction with clinically grounded dosing rules. Validation on real outcome data and physical hardware is identified as the next steps toward clinical translation.
Authors
- Jasti Sateesh (ORCID: https://orcid.org/0000-0002-3459-8253)
- Turimerla Pratap (ORCID: https://orcid.org/0000-0002-6700-9822)
- G. Kalyani (ORCID: https://orcid.org/0000-0001-8544-6930)
Publication Details
- Journal
- Artificial Organs
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1111/aor.70278
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00